Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Paula Zapata-Cobo, Sara Salvador‐Martín, Marta Velasco Rodríguez‐Belvís, et al.
Pharmacological Research (2023) Vol. 194, pp. 106859-106859
Open Access | Times Cited: 10

Showing 10 citing articles:

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers
Antonio Meštrović, Nikola Perković, Dorotea Božić, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1520-1520
Open Access | Times Cited: 6
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine
Matthew B. Stanton, Mark Solinski, Stephen B. Hanauer
Expert Review of Clinical Immunology (2025), pp. 1-12
Closed Access
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review
Octavio Ballesta‐López, M Gil Candel, María Centelles-Oria, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1760-1760
Open Access
Precision medicine in inflammatory bowel disease
Zhen Zeng, Mingshan Jiang, Xi Li, et al.
Precision Clinical Medicine (2023) Vol. 6, Iss. 4
Open Access | Times Cited: 11
A review on current advancement in zebrafish models to study chronic inflammatory diseases and their therapeutic targets
Akshad Balde, Cunnathur Saravanan Ramya, Rasool Abdul Nazeer
Heliyon (2024) Vol. 10, Iss. 11, pp. e31862-e31862
Open Access | Times Cited: 3
Understanding patient variability to biologic treatments in inflammatory bowel disease
Ahmad Z. Al Meslamani
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 317-319
Open Access | Times Cited: 2
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities
Clelia Cicerone, Ferdinando D’Amico, Mariangela Allocca, et al.
Diagnostics (2024) Vol. 14, Iss. 14, pp. 1530-1530
Open Access
Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease
Milena Peruhova, D. Stoyanova, Dimitrina Georgieva Miteva, et al.
World Journal of Experimental Medicine (2024) Vol. 15, Iss. 1
Closed Access
Comment: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Chin‐Yuan Yii, Hsien Hung Chiu, Su‐Boon Yong
Pharmacological Research (2023) Vol. 196, pp. 106937-106937
Open Access
Page 1

Scroll to top